|Articles|June 18, 2018

CDC Announces Multistate Salmonella Outbreak Linked With Kellogg's Honey Smacks Cereal

The CDC has linked Kellogg’s Honey Smacks Cereal with a multistate outbreak of Salmonella.

The US Centers for Disease Control and Prevention (CDC) is investigating yet another multistate outbreak of Salmonella. Where last week, a multistate outbreak of Salmonella Adelaide had been traced back to pre-cut melon produced and distributed by Caito Foods LLC, this new outbreak has been linked with a breakfast favorite: Kellogg’s Honey Smacks cereal.

As of September 5, 2018, 7130cases of Salmonella Mbandka have been reported across 36 states. While 34 hospitalizations have been reported, there have been no reported deaths at this time.

According to the CDC, the infected individuals range from less than 1 year to 95 years of age, with a median age of 57. Available data indicate that 69% of individuals that have been infected are female. The reported dates of illness range from March 3 to August 7, but according to the CDC, Salmonella can take up to 2 to 4 weeks to diagnose and report. As such, any illnesses that have occurred after August 4 may not have been reported yet.

As part of the investigation, interviews were conducted with 79 individuals who have become ill. Of the interviewees 61 individuals or 77% specifically reported consumption of Kellogg’s Honey Smacks cereal, according to the CDC.

On June 14, 2018, Kellogg’s issued a recall for Honey Smacks cereal. The recall includes 15.3 oz and 23 oz boxes of the cereal with a “best if used by” date of June 18, 2018 to June 18, 2019. The products have been distributed across the United States and also have had limited distribution in the Caribbean, Costa Rica, Guam, Guatemala, Mexico, Saipan, and Tahiti, according to a recall posted by the US Food and Drug Administration (FDA.)

The CDC advises to throw out the recalled Honey Smacks cereal, and if it has been stored in a reusable container, to thoroughly wash the container with warm soapy water before further use to prevent the spread of germs to other products.

Common symptoms associated with Salmonella infection include fever, diarrhea, nausea, vomiting, and stomach cramps, which can begin occurring 12 to 72 hours after contact with the germ. If you are a health care provider practicing in one of the states affected by the outbreak, be cognizant of any patients who present with such symptoms.

The CDC will provide updates to the outbreak as information becomes available.

For the most recent case counts and states affected by the Salmonella outbreak linked to Kellogg’s Honey Smacks cereal, be sure to check out the Contagion® Outbreak Monitor.

Updated 9/5/2018 at 10:17 am EDT to reflect updated case counts.


Related to this article

This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.